Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression

Hicham Lahlou, Virginie Sanguin-Gendreau, Dongmei Zuo, Robert Cardiff, Gordon W. McLean, Margaret C. Frame, William J. Muller

Research output: Contribution to journalArticle

140 Citations (Scopus)

Abstract

Elevated expression and activation of the focal adhesion kinase (FAK) occurs in a large proportion of human breast cancers. Although several studies have implicated FAK as an important signaling molecule in cell culture systems, evidence supporting a role for FAK in mammary tumor progression is lacking. To directly assess the role of FAK in this process, we have used the Cre/loxP recombination system to disrupt FAK function in the mammary epithelium of a transgenic model of breast cancer. Using this approach, we demonstrate that FAK expression is required for the transition of premalignant hyperplasias to carcinomas and their subsequent metastases. This dramatic block in tumor progression was further correlated with impaired mammary epithelial proliferation. These observations provide direct evidence that FAK plays a critical role in mammary tumor progression.

Original languageEnglish (US)
Pages (from-to)20302-20307
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume104
Issue number51
DOIs
StatePublished - Dec 18 2007

Fingerprint

Focal Adhesion Protein-Tyrosine Kinases
Breast
Breast Neoplasms
Genetic Recombination
Hyperplasia
Epithelium
Cell Culture Techniques
Neoplasm Metastasis
Carcinoma

Keywords

  • Breast cancer
  • Cre recombinase
  • Transgenic

ASJC Scopus subject areas

  • General

Cite this

Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression. / Lahlou, Hicham; Sanguin-Gendreau, Virginie; Zuo, Dongmei; Cardiff, Robert; McLean, Gordon W.; Frame, Margaret C.; Muller, William J.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, No. 51, 18.12.2007, p. 20302-20307.

Research output: Contribution to journalArticle

Lahlou, Hicham ; Sanguin-Gendreau, Virginie ; Zuo, Dongmei ; Cardiff, Robert ; McLean, Gordon W. ; Frame, Margaret C. ; Muller, William J. / Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression. In: Proceedings of the National Academy of Sciences of the United States of America. 2007 ; Vol. 104, No. 51. pp. 20302-20307.
@article{1ebd92868fe6448bbe8b712bbe674638,
title = "Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression",
abstract = "Elevated expression and activation of the focal adhesion kinase (FAK) occurs in a large proportion of human breast cancers. Although several studies have implicated FAK as an important signaling molecule in cell culture systems, evidence supporting a role for FAK in mammary tumor progression is lacking. To directly assess the role of FAK in this process, we have used the Cre/loxP recombination system to disrupt FAK function in the mammary epithelium of a transgenic model of breast cancer. Using this approach, we demonstrate that FAK expression is required for the transition of premalignant hyperplasias to carcinomas and their subsequent metastases. This dramatic block in tumor progression was further correlated with impaired mammary epithelial proliferation. These observations provide direct evidence that FAK plays a critical role in mammary tumor progression.",
keywords = "Breast cancer, Cre recombinase, Transgenic",
author = "Hicham Lahlou and Virginie Sanguin-Gendreau and Dongmei Zuo and Robert Cardiff and McLean, {Gordon W.} and Frame, {Margaret C.} and Muller, {William J.}",
year = "2007",
month = "12",
day = "18",
doi = "10.1073/pnas.0710091104",
language = "English (US)",
volume = "104",
pages = "20302--20307",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "51",

}

TY - JOUR

T1 - Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression

AU - Lahlou, Hicham

AU - Sanguin-Gendreau, Virginie

AU - Zuo, Dongmei

AU - Cardiff, Robert

AU - McLean, Gordon W.

AU - Frame, Margaret C.

AU - Muller, William J.

PY - 2007/12/18

Y1 - 2007/12/18

N2 - Elevated expression and activation of the focal adhesion kinase (FAK) occurs in a large proportion of human breast cancers. Although several studies have implicated FAK as an important signaling molecule in cell culture systems, evidence supporting a role for FAK in mammary tumor progression is lacking. To directly assess the role of FAK in this process, we have used the Cre/loxP recombination system to disrupt FAK function in the mammary epithelium of a transgenic model of breast cancer. Using this approach, we demonstrate that FAK expression is required for the transition of premalignant hyperplasias to carcinomas and their subsequent metastases. This dramatic block in tumor progression was further correlated with impaired mammary epithelial proliferation. These observations provide direct evidence that FAK plays a critical role in mammary tumor progression.

AB - Elevated expression and activation of the focal adhesion kinase (FAK) occurs in a large proportion of human breast cancers. Although several studies have implicated FAK as an important signaling molecule in cell culture systems, evidence supporting a role for FAK in mammary tumor progression is lacking. To directly assess the role of FAK in this process, we have used the Cre/loxP recombination system to disrupt FAK function in the mammary epithelium of a transgenic model of breast cancer. Using this approach, we demonstrate that FAK expression is required for the transition of premalignant hyperplasias to carcinomas and their subsequent metastases. This dramatic block in tumor progression was further correlated with impaired mammary epithelial proliferation. These observations provide direct evidence that FAK plays a critical role in mammary tumor progression.

KW - Breast cancer

KW - Cre recombinase

KW - Transgenic

UR - http://www.scopus.com/inward/record.url?scp=38049098089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38049098089&partnerID=8YFLogxK

U2 - 10.1073/pnas.0710091104

DO - 10.1073/pnas.0710091104

M3 - Article

C2 - 18056629

AN - SCOPUS:38049098089

VL - 104

SP - 20302

EP - 20307

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 51

ER -